Skip to content

Released Aug 8, 2017, after the close

10-Q filed Aug 8, 2017, 39 days after period end · 0001162194-17-000091

Q2 2017 · 10-Q
Revenue$23.91M−15.1% vs Q2 2016−6.3% vs Q1 2017
Net Income-$16.93MN/M vs Q2 2016N/M vs Q1 2017
EPS Diluted-$0.58N/M vs Q2 2016N/M vs Q1 2017
Operating Income-$16,487,000N/M
Operating Cash Flowderived-$8,290,000N/M
Free Cash Flowderived-$8,432,000N/M
Margins · derived
Operating margin-68.9%−4.5 pt vs Q2 2016
Net margin-70.8%−4.7 pt vs Q2 2016

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ2 2017Q2 2016Q2 2015Q2 2014
Revenue$23.91M$28.17M$28.62M$27.61M
Net Income-$16.93M-$18.62M-$15.24M-$12.68M
EPS Diluted-$0.58-$0.64-$0.53-$0.45

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Standard Biotools Inc. · CIK 1162194 · Engraved from SEC EDGAR